X4 Pharmaceuticals (XFOR) Accumulated Depreciation (2017 - 2019)

X4 Pharmaceuticals has reported Accumulated Depreciation for 3 years, with the latest figure at $305000.0 in Q2 2019.

• For the quarter ending Q2 2019, Accumulated Depreciation changed N/A year-over-year to $305000.0; the trailing twelve-month figure through Jun 2019 stood at $305000.0 (changed N/A YoY), and the FY2018 full-year result was $176000.0, down 92.08% from the prior year.
• Accumulated Depreciation for Q2 2019 stood at $305000.0, up from $177000.0 in the prior quarter.
• The five-year high for Accumulated Depreciation was $2.3 million in Q1 2018, with the low at $176000.0 in Q4 2018.
• Historically, Accumulated Depreciation has averaged $1.0 million across 3 years, with a median of $305000.0 in 2019.
• Annual changes were most pronounced in 2018 — Accumulated Depreciation slumped 92.08% — and 2019, when it slumped 92.38%.
• X4 Pharmaceuticals' Accumulated Depreciation stood at $2.2 million in 2017, then tumbled by 92.08% to $176000.0 in 2018, then jumped by 73.3% to $305000.0 in 2019.
• The last three Accumulated Depreciation figures came in at $305000.0 (Q2 2019), $177000.0 (Q1 2019), and $176000.0 (Q4 2018), per Business Quant data.